Patents by Inventor Mark E. Schnute

Mark E. Schnute has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110009435
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable salts thereof, processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as anti-inflammatory agents.
    Type: Application
    Filed: May 19, 2008
    Publication date: January 13, 2011
    Applicant: Pfizer, Inc.
    Inventors: Mark E. Schnute, Peter G. Ruminski, Cathleen E. Hanau, Joseph W. Stobach, Jeffery Carroll, Kirby Sample
  • Patent number: 6903097
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: June 7, 2005
    Assignee: Pharmacia & Upjohn Company
    Inventors: Fred L. Ciske, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt
  • Patent number: 6878705
    Abstract: The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: April 12, 2005
    Assignee: Pfizer
    Inventors: Michele M. Cudahy, Mark E. Schnute, Steven P. Tanis, William R. Perrault, Paul Matthew Herrinton, Sajiv K. Nair
  • Patent number: 6861438
    Abstract: The invention provides a compound of formula I: wherein G, R2, and R3 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: March 1, 2005
    Assignee: Pfizer
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis
  • Patent number: 6852731
    Abstract: The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: February 8, 2005
    Assignee: Pfizer
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner
  • Publication number: 20040259907
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: December 23, 2004
    Inventors: Michele M. Cudahy, Mark E. Schnute, Steven P. Tanis, William R. Perrault, Paul Matthew Herrinton, Sajiv K. Nair
  • Patent number: 6831081
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: December 14, 2004
    Assignee: Pharmacia & Upjohn
    Inventors: Mark E. Schnute, Fred L. Ciske, Michael J. Genin, Joseph Walter Strohbach, Suvit Thaisrivongs
  • Publication number: 20040242884
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: December 2, 2004
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner
  • Publication number: 20040180910
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: March 29, 2004
    Publication date: September 16, 2004
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt, Scott D. Larsen
  • Publication number: 20040142928
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: December 23, 2003
    Publication date: July 22, 2004
    Inventors: Gordon L. Bundy, Fred L. Ciske, Michael J. Genin, Steven E. Heasley, Scott D. Larsen, Byung Hyun Lee, Paul D. May, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt, Atli Thorarensen, Allison J. Wolf, Nancy Anne Wicnienski, David Wilhite
  • Publication number: 20040138449
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: July 15, 2004
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis
  • Publication number: 20040116464
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Application
    Filed: August 27, 2003
    Publication date: June 17, 2004
    Inventors: Mark E. Schnute, Michele M. Cudahy, Fred L. Ciske, Michael J. Genin, David John Anderson, Thomas M. Judge, MariJean Eggen, Sarah A. Collier
  • Publication number: 20040110787
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Application
    Filed: August 27, 2003
    Publication date: June 10, 2004
    Inventors: Mark E. Schnute, Michele M. Cudahy, David John Anderson, Thomas M. Judge, Thomas J. Fleck, Paul Matthew Herrinton, Sajiv K. Nair, Allen Scott, William R. Perrault, Steve P. Tanis, James A. Nieman, Sarah A. Collier, Bruce F. Fleck
  • Publication number: 20040110786
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Application
    Filed: August 27, 2003
    Publication date: June 10, 2004
    Inventors: Mark E. Schnute, Fred L. Ciske, Michael J. Genin, Joseph Walter Strohbach, Suvit Thaisrivongs
  • Patent number: 6730682
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: May 4, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt
  • Publication number: 20040029879
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: July 31, 2003
    Publication date: February 12, 2004
    Inventors: David John Anderson, Thomas J. Beauchamp, Gordon L. Bundy, Fred L. Ciske, John R. Farrell, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Ronald Turner, Valerie A. Vaillancourt, Allison J. Wolf
  • Publication number: 20040024209
    Abstract: The present invention provides compounds of formula I 1
    Type: Application
    Filed: July 21, 2003
    Publication date: February 5, 2004
    Inventor: Mark E. Schnute
  • Patent number: 6653307
    Abstract: The present invention provides compounds of formula I which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 5, 2001
    Date of Patent: November 25, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventor: Mark E. Schnute
  • Publication number: 20030207880
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: December 18, 2002
    Publication date: November 6, 2003
    Inventors: Gordon L. Bundy, Fred L. Ciske, Michael J. Genin, Steven E. Heasley, Scott D. Larsen, Byung Hyun Lee, Paul D. May, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt, Atli Thorarensen, Allison J. Wolf, Nancy Anne Wicnienski, David Wilhite
  • Patent number: 6624159
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: September 23, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: David John Anderson, Gordon L. Bundy, Fred L. Ciske, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Ronald Turner, Valerie A. Vaillancourt, Allison J. Wolf